A Trial to Evaluate the Efficacy and Safety of EFLA400 Korea Red Ginseng Extract on Sexual Function in Men With Erectile Dysfunction
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01479426 |
|
Recruitment Status : Unknown
Verified December 2010 by Chonbuk National University Hospital.
Recruitment status was: Enrolling by invitation
First Posted : November 24, 2011
Last Update Posted : November 24, 2011
|
Sponsor:
Chonbuk National University Hospital
Information provided by:
Chonbuk National University Hospital
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
Brief Summary:
Korea red ginseng has been used in maintaining vitality throughout the globally and metabolism and actions on neurologic, cardiovascular, and endocrinologic system are studied. KRG has been used in various ailment, and to prove its efficacy for erectile dysfunction an international study on contries other than Korean was performed. In the present study, subjects with borderline organic and psychogenic erectile dysfunction will be included. KRG will be give daily, and placebo will be give as control. Outcomes including libido, erection, sexual activity, and sexual satisfaction will be measured.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Healthy Subjects(Only Men) | Dietary Supplement: EFLA400 Dietary Supplement: Placebo | Phase 2 Phase 3 |
Among the three main lines of therapy for erectile dysfunction (ED), that is, oral therapy, self-injection therapy and penile prosthesis implantation, the first line therapy is always the first option. Despite the successful advent of sildenafil, the first effective oral agent for ED, further development of new drugs and phytochemical studies of widely known herbal plants are desirable. Furthermore, there seems to be a large population that prefers to use phytotherapies rather than pharmaceutical drugs for their health. Korean red ginseng, a phytotherapy plants, used frequently for ED. Ginseng is one of the most popular herbs in both Eastern and Western countries. It is known as a traditional Asian medicine for stimulation of sexual function and studies have shown the effects of ginseng on relaxation of penile corpus cavernous smooth muscle in many studies. In the present study, the investigators will be determined the real role of Korean red ginseng in the treatment of ED.
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 80 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Double (Participant, Investigator) |
| Primary Purpose: | Prevention |
| Official Title: | Efficacy and Safety of EFLA400 Korea Red Ginseng Extract on Erectile Dysfunction |
| Study Start Date : | December 2010 |
| Estimated Primary Completion Date : | March 2012 |
| Estimated Study Completion Date : | July 2012 |
Resource links provided by the National Library of Medicine
MedlinePlus related topics:
Erectile Dysfunction
Drug Information available for:
Ginseng
| Arm | Intervention/treatment |
|---|---|
| Experimental: EFLA400(960mg) |
Dietary Supplement: EFLA400
EFLA400(960mg/day)for 12 weeks
Other Name: EFLA400 Korean red ginseng |
| Placebo Comparator: Placebo(960mg) |
Dietary Supplement: Placebo
Placebo(960mg/day) for 12 weeks |
Primary Outcome Measures :
- IIEF-5 score [ Time Frame: Change from baseline in IIEF-5 score at 12 weeks ]
Secondary Outcome Measures :
- MSHQ [ Time Frame: Change from baseline in MSHQ score at 12 weeks ]
- GEAQ [ Time Frame: Change from baseline in GEAQ score at 12 weeks ]
- uroflowmetry(max flow rate) [ Time Frame: Change from baseline in uroflowmetry at 12 weeks ]
Information from the National Library of Medicine
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 35 Years to 65 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | Male |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- aged 35-65 years
- IIEF-5 scores between 13 and 21
Exclusion Criteria:
- they had other neurologic or psychiatric disorder
- significant hepatic or renal function impairment (hepatic enzymes >1.5 times the upper limit of normal and/or serum creatinine >1.8 mg per 100 ml)
- hypertension (>170/110 mm Hg), hypotension (<90/50 mm Hg) or significant cardiovascular disease (unstable angina, coronary artery disease, myocardial infarction or myocardial revascularization).
- Peyronie's disease
Information from the National Library of Medicine
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01479426
Locations
| Korea, Republic of | |
| Clinical Trial Center for Functional Foods; Chonbuk National University Hospital | |
| Jeonju, Jeollabuk-do, Korea, Republic of, 560-822 | |
Sponsors and Collaborators
Chonbuk National University Hospital
Investigators
| Principal Investigator: | Jong-Kwan Park, MD | Chonbuk National University Hospital |
| ClinicalTrials.gov Identifier: | NCT01479426 History of Changes |
| Other Study ID Numbers: |
LOTTE-MS-EFLA400 |
| First Posted: | November 24, 2011 Key Record Dates |
| Last Update Posted: | November 24, 2011 |
| Last Verified: | December 2010 |
Keywords provided by Chonbuk National University Hospital:
|
Erectile dysfunction Korean Red Ginseng IIEF MSHQ |
Additional relevant MeSH terms:
|
Erectile Dysfunction Sexual Dysfunction, Physiological Genital Diseases, Male Sexual Dysfunctions, Psychological Mental Disorders |